1Nedelec B,Shankowsky H,Scott PG,et al.Myofibroblasts and apoptosis in human hypertrophic scars:the effect of interferon-alpha2b.Surgery,2001,130(5):798.
1Ohno T, Nakajima K, Kojima M, et al. Modifiers of the jumonji mutation downregulate cyclin D1 expression and cardiac cell proliferation. Biochem Biophys Res Commun 2004; 317 (3): 925 - 9.
2Joo M, Lee HK, Kang YK. Expression of beta-catenin in hepatocellular carcinoma in relation to tumor cell proliferation and cyclin D1 expression. J Korean Med Sci 2003; 18(2):211 -7.
3Alldridge LC, Bryant CE. Annexin 1 regulates cell proliferation by disruptioh of cell morphology and inhibition of cyclin D1 expression through sustained activation of the ERK 1/2 MAPK signal. Exp Cell Res 2003; 290 (1): 93 - 107.
4Nedelec B,Shankowsky HA,Tredget EE.Rating the resolving hypertrophic scar:comparison of the Vancouver Scar Scale and scar volume.JBurn Care Rehabil 2000;21(3):205-12.
5Liu SC,Klein-Szanto AJ Markers of proliferation in normal andleukoplakic oral epithelia Oral Oncol 2000;36(2):145-51.
6Ehrlich HP, Desmuliere A. Diegelmann RF, et al. Morphological and immunochemical differences between keloid and hypertrophic scars[J]. Am J Pathol,1994,145(1) :105-113.
7Nedelec B, Shankowsky H, Scott PG, et al. Myofibroblasts and apoptosis in human hypertrophic scars:the effect of interferon-alpha2b[J]. Surgery, 2001,130(5): 798-808.
8Ormandy CJ, Musgrove EA, Hui R, et al. Cyclin DI,EMS1 and 11q13 amplification in breast cancer[J]. Breast Cancer Res Treat,2003,78(3) :323-335.
9Schuuring E. The involvement of the chromosome 11q13 region in human malignancies:cyclinD1 and EMS1 are two candidate oncogenes-a review[J]. Gene, 1998,159(1) :83-96.
10Rocco JW, Sidransky D. p16(MTS-1/CDKN2/INK4a) in cancer progression [J]. Exp Cell Res, 2001,264(1): 42-55.
